Cargando…
Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model
BACKGROUND: The medical care of malaria is a clinical emergency because it may develop into severe malaria, which has a high risk of complications and death. One of the major complications of Plasmodium falciparum infections is cerebral malaria (CM), which is responsible for at least 175,000 deaths...
Autores principales: | Dormoi, Jérôme, Briolant, Sébastien, Pascual, Aurélie, Desgrouas, Camille, Travaillé, Christelle, Pradines, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765719/ https://www.ncbi.nlm.nih.gov/pubmed/23988087 http://dx.doi.org/10.1186/1475-2875-12-302 |
Ejemplares similares
-
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model
por: Dormoi, Jérome, et al.
Publicado: (2013) -
Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model
por: Souraud, Jean-Baptiste, et al.
Publicado: (2012) -
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum
por: Parquet, Véronique, et al.
Publicado: (2010) -
PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria
por: Gaillard, Tiphaine, et al.
Publicado: (2013) -
In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum
por: Dormoi, Jérome, et al.
Publicado: (2014)